GLPwatch

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists.

J Drugs Dermatol · 2024

Last updated 2026-05-28
JournalJ Drugs Dermatol, 2024
Citations6
Relative citation ratio1.46
NIH percentile63
Molecules —

Full record and abstract on PubMed 39231072 ↗